Walleye Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.87M Sell
13,600
-7,600
-36% -$1.64M 0.01% 1182
2025
Q4
$4.36M Sell
21,200
-14,200
-40% -$2.67M 0.01% 1249
2025
Q3
$5.56M Buy
35,400
+25,200
+247% +$3.89M 0.02% 866
2025
Q2
$1.71M Sell
10,200
-24,000
-70% -$3.56M 0.01% 1642
2025
Q1
$4.71M Sell
34,200
-8,500
-20% -$1.08M 0.02% 823
2024
Q4
$5.05M Buy
42,700
+6,100
+17% +$712K 0.01% 1066
2024
Q3
$4.05M Buy
36,600
+22,200
+154% +$2.32M 0.01% 1335
2024
Q2
$1.42M Sell
14,400
-35,900
-71% -$3.66M ﹤0.01% 2471
2024
Q1
$5.63M Sell
50,300
-43,700
-46% -$4.72M 0.01% 1207
2023
Q4
$9.48M Buy
94,000
+49,300
+110% +$4.89M 0.02% 698
2023
Q3
$3.88M Buy
44,700
+18,100
+68% +$1.64M 0.01% 1216
2023
Q2
$2.52M Buy
26,600
+19,400
+269% +$1.64M 0.01% 1182
2023
Q1
$544K Buy
7,200
+5,900
+454% +$445K 0.01% 1642
2022
Q4
$99.9K Sell
1,300
-56,100
-98% -$4.26M ﹤0.01% 2366
2022
Q3
$3.83M Buy
+57,400
New +$3.64M 0.07% 290

Other funds holding CAH

Walleye Capital's CAH Position: Q1 2026 in Review

Walleye Capital reduced its Cardinal Health (CAH) stake by 97% in Q1 2026, selling an estimated $17M and leaving 2,410 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #2652.

Walleye Capital first reported a position in CAH in Q3 2018 and has held it in 16 quarters since. The position peaked at $38.8M in Q3 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Walleye Capital held 2,410 shares of Cardinal Health worth $509K as of Q1 2026.
  • Walleye Capital sold 78,892 Cardinal Health shares in Q1 2026, an estimated $17M.
  • Cardinal Health made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2652 holding.
  • Walleye Capital first reported a position in Cardinal Health in Q3 2018 and has held it in 16 quarters since.
  • Walleye Capital's Cardinal Health position peaked at $38.8M in Q3 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.